Mergers & Acquisitions · Jan 15, 2026

Boston Scientific Corporation entered into a definitive merger agreement to acquire Penumbra, Inc., with shareholders…

BSXBoston Scientific Corp

Boston Scientific Corporation entered into a definitive merger agreement to acquire Penumbra, Inc., with shareholders receiving either $374.00 in cash or 3.8721 shares of Boston Scientific common stock per share, subject to a proration of 73.26% cash and 26.74% stock. The transaction includes termination fees of $525 million payable by Penumbra and $900 million payable by Boston Scientific under specific circumstances.